Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant - Hiwarkar, P; Amrolia, P; Sivaprakasam, P; United Kingdom Paediatric Bone Marrow Transplant Group (Blood, 2017)